Rankings
▼
Calendar
XOMAP FY 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$38M
+29.9% YoY
Gross Profit
$38M
99.6% margin
Operating Income
$18M
45.9% margin
Net Income
$16M
41.4% margin
EPS (Diluted)
$0.65
Cash Flow
Operating Cash Flow
$23M
Free Cash Flow
-$4M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$167M
Total Liabilities
$25M
Stockholders' Equity
$142M
Cash & Equivalents
$93M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$38M
$29M
+29.9%
Gross Profit
$38M
$29M
+30.0%
Operating Income
$18M
$12M
+41.2%
Net Income
$16M
$13M
+18.8%
← Q4 2020
All Quarters
Q1 2021 →